| Literature DB >> 18214969 |
Michele Spina1, Massimiliano Cuccioloni, Matteo Mozzicafreddo, Francesca Montecchia, Stefania Pucciarelli, Anna Maria Eleuteri, Evandro Fioretti, Mauro Angeletti.
Abstract
Dihydrofolate reductase (DHFR) is a ubiquitous enzyme involved in major biological process, including DNA synthesis and cancer inhibition, and its modulation is the object of extensive structural, kinetic, and pharmacological studies. In particular, earlier studies showed that green tea catechins are powerful inhibitors of bovine liver and chicken liver DHFR. In this article, we report the results of inhibition kinetics for the enzyme from another source (DHFR from E. coli) exerted by (-)-epigallocatechingallate (EGCG). Using different analytical techniques, we reported that EGCG acts as a bisubstrate inhibitor on the bacterial DHFR. Moreover, the combined approach of biosensor, kinetic, and molecular modelling analysis disclosed the ability of EGCG to bind to the enzyme both on substrate (DHF) and cofactor (NADPH) site. Collectively, our data have confirmed the selectivity of antifolate compounds with respect to the different source of enzyme (bacterial or mammalian DHFR) and the possible role of tea catechins as chemopreventive agents. 2008 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18214969 DOI: 10.1002/prot.21914
Source DB: PubMed Journal: Proteins ISSN: 0887-3585